UK markets open in 1 hour 20 minutes
NIKKEI 225
39,064.41 +447.31 (+1.16%) HANG SENG
18,862.17 -333.43 (-1.74%) CRUDE OIL
76.99 -0.58 (-0.75%) GOLD FUTURES
2,372.20 -20.70 (-0.87%) DOW
39,671.04 -201.95 (-0.51%) Bitcoin GBP
54,495.42 -375.15 (-0.68%)
Catalent, Inc. (CTLT)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 54.96 |
| Open | 54.98 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 800 |
| Day's range | 54.76 - 55.19 |
| 52-week range | 31.80 - 60.20 |
| Volume | |
| Avg. volume | 1,833,203 |
| Market cap | 9.948B |
| Beta (5Y monthly) | 1.18 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -6.48 |
| Earnings date | 17 May 2024 - 21 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 56.70 |
ZacksCatalent's (CTLT) Latest Partnership to Boost Clinical Trials
Catalent's (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving treatments to cancer patients.
ZacksCatalent (CTLT) Q3 Earnings Lag Estimates, Gross Margin Up
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.
GuruFocus.comDecoding Catalent Inc (CTLT): A Strategic SWOT Insight
Insightful Analysis of Catalent Inc's Strengths, Weaknesses, Opportunities, and Threats
© 2024 Yahoo. All rights reserved.